Physician profile
Sean Lynch
NPI 1427439132
$1,358.93
in general payments reported to CMS, 2019-2025
15 companies · $504 in 2025
The $504 reported for 2025 was more than what a typical Foot Surgery provider received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $71.80 · 2020: $57.43 · 2021: $74.92 · 2022: $111 · 2023: $152 · 2024: $387 · 2025: $504.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,043.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,043.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $608.19 | 2023-2025 | Grafix Pl, Grafix |
| Integra Lifesciences Corporation | $125.10 | 2021-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Stryker Corporation | $124.81 | 2020-2023 | Ortholoc 2 Lapifuse |
| Treace Medical Concepts, INC. | $100.32 | 2024-2025 | |
| Nevro Corp. | $87.62 | 2022 | |
| Paratek Pharmaceuticals, INC. | $62.77 | 2020-2025 | Nuzyra |
| Ani Pharmaceuticals, INC. | $51.95 | 2025 | Purified Cortrophin Gel |
| Orthofix Medical, INC. | $35.31 | 2025 | Physio-Stim |
| Acumed LLC | $35.03 | 2024 | Osteomed |
| Linvatec Corporation | $31.00 | 2019 | |
| Osteomed LLC | $28.78 | 2019 | |
| Djo, LLC | $22.07 | 2024 | Cmf |
| Hartmann USA, INC. | $17.17 | 2025 | Zetuvit Plus 10x10 P10 |
| Kerecis Limited | $16.79 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Arthrosurface Incorporated | $12.02 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sean Lynch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.